141 bytes added ,  16:31, 23 August 2009
Line 17: Line 17:     
==Description==
 
==Description==
'''Insulinomas''' are slow growing, well-encapsulated, functional tumours of the [[Pancreas - Anatomy & Physiology#Endocrine|beta cells]] of the pancreatic islet cells.  They secrete inappropriately high amount of [[Pancreas - Anatomy & Physiology#Insulin|insulin]] irrespective of the serum glucose level.  They are predominantly malignant (90% of canine insulinomas), with a high metastatic rate to regional lymph nodes, liver and omentum.  60% of isulinomas are carcinomas, which are more likely to be endocrinologically active, the others being adenomas.
+
'''Insulinomas''' are slow growing, well-encapsulated, functional tumours of the [[Pancreas - Anatomy & Physiology#Endocrine|beta cells]] of the pancreatic islet cells.  They secrete inappropriately high amount of [[Pancreas - Anatomy & Physiology#Insulin|insulin]] irrespective of the serum glucose level.  They are predominantly [[Neoplasia - Pathology#Classification|malignant]] (90% of canine insulinomas), with a high metastatic rate to regional [[Lymph Nodes - Pathology|lymph nodes]], [[Liver - Anatomy & Physiology|liver]] and omentum.  60% of isulinomas are [[Neoplasia - Pathology#Nomenclature|carcinomas]], which are more likely to be endocrinologically active, the others being adenomas.
    
==Diagnosis==
 
==Diagnosis==
592

edits